AZRX Stock Forecast 2025-2026
Distance to AZRX Price Targets
AZRX Price Momentum
🤔 Considering AzurRx (AZRX)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Latest AZRX Stock Price Targets & Analyst Predictions
AZRX has shown a year-to-date change of -26.2% and a 1-year change of -90.1%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for AZRX. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AZRX Analyst Ratings
AZRX Price Target Range
Latest AZRX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AZRX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
AzurRx BioPharma Inc (AZRX) Competitors
The following stocks are similar to AzurRx based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
AzurRx BioPharma Inc (AZRX) Financial Data
AzurRx BioPharma Inc has a market capitalization of $37.87M with a P/E ratio of 0.0x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of N/A and return on equity of +43.3%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
AzurRx BioPharma Inc (AZRX) Business Model
About AzurRx BioPharma Inc
Company Information
AzurRx BioPharma Inc (AZRX) Latest News & Analysis
The company will start trading on Nasdaq under the new ticker symbol "FBWI" effective September 22.
The new ticker symbol “FBWI” on Nasdaq may indicate a rebranding or strategic shift, affecting investor perception and trading volume. Monitoring performance post-change is crucial.
AzurRx BioPharma Inc (NASDAQ: AZRX) will acquire First Wave Bio Inc for $229 million in stock and cash, focusing on therapies for autoimmune inflammatory bowel diseases.
The acquisition could enhance AzurRx's pipeline and market position in the IBD space, potentially increasing future revenue and shareholder value.
AzurRx BioPharma's CEO James Sapirstein discussed the acquisition of First Wave Bio during a recent conference call, highlighting strategic plans and potential benefits for the company.
The acquisition may signal growth potential for AzurRx, impacting its market position and future revenue streams, influencing investor sentiment and stock performance.
AzurRx BioPharma will be renamed First Wave BioPharma and will begin trading under the new NASDAQ ticker symbol FWBI.
The rebranding to First Wave BioPharma and new ticker symbol FWBI may signal a strategic shift, potentially impacting investor sentiment and stock performance.
AzurRx BioPharma, now named First Wave BioPharma, announced its merger with First Wave Bio, enhancing its focus on non-systemic therapies for gastrointestinal diseases.
The merger and rebranding signal a strategic shift that could enhance growth potential and market positioning, impacting stock performance and investor sentiment.
AzurRx BioPharma (AZRX) has acquired First Wave Bio for $229 million and will rebrand itself as First Wave BioPharma post-acquisition.
The acquisition could enhance AzurRx's market position and product offerings, potentially impacting stock value and investor confidence in future growth prospects.
Frequently Asked Questions About AZRX Stock
What is AzurRx BioPharma Inc's (AZRX) stock forecast for 2025?
Analyst forecasts for AzurRx BioPharma Inc (AZRX) are not currently available. The stock is trading at $0.48.
Is AZRX stock a good investment in 2025?
Analyst ratings for AZRX are not currently available. The stock is currently trading at $0.48. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for AZRX stock?
Price predictions from Wall Street analysts for AZRX are not currently available. The stock is trading at $0.48.
What is AzurRx BioPharma Inc's business model?
N/A
What is the highest forecasted price for AZRX AzurRx BioPharma Inc?
Price targets from Wall Street analysts for AZRX are not currently available. The stock is trading at $0.48.
What is the lowest forecasted price for AZRX AzurRx BioPharma Inc?
Price targets from Wall Street analysts for AZRX are not currently available. The stock is trading at $0.48.
What is the overall AZRX consensus from analysts for AzurRx BioPharma Inc?
Analyst ratings for AZRX are not currently available. The stock is trading at $0.48.
How accurate are AZRX stock price projections?
Stock price projections, including those for AzurRx BioPharma Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
